Net profit of Procter & Gamble Health declined 14.64% to Rs 77.59 crore in the quarter ended December 2025 as against Rs 90.90 crore during the previous quarter ended December 2024. Sales rose 20.69% to Rs 373.86 crore in the quarter ended December 2025 as against Rs 309.77 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales373.86309.77 21 OPM %29.5539.85 - PBDT114.72127.24 -10 PBT108.82121.69 -11 NP77.5990.90 -15 Powered by Capital Market - Live News

Procter & Gamble Health announced that the Board of Directors of the Company at its meeting held on 06 February 2026, has recommended a Interim Dividend of Rs.110 per share (i.e.1100%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Procter & Gamble Health announced that the Board of Directors of the Company at its meeting held on 06 February 2026, has recommended a One-time Special Dividend of Rs.50 per share (i.e.500%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live News

Net profit of Procter & Gamble Health rose 7.54% to Rs 88.54 crore in the quarter ended September 2025 as against Rs 82.33 crore during the previous quarter ended September 2024. Sales rose 3.67% to Rs 324.92 crore in the quarter ended September 2025 as against Rs 313.41 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales324.92313.41 4 OPM %37.0236.39 - PBDT125.10117.17 7 PBT119.02111.40 7 NP88.5482.33 8 Powered by Capital Market - Live News